Simpler HIV pill for teens shows promise in major trial
NCT ID NCT03682848
Summary
This study tested a simpler, two-drug HIV treatment in teenagers who had never taken HIV medication before. The goal was to see if taking fewer drugs could still effectively control the virus for up to three years while potentially reducing long-term side effects. Thirty-two adolescents took a single daily pill containing two medications and were monitored closely for safety and how well the virus was suppressed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Kericho, 20200, Kenya
-
GSK Investigational Site
Kisumu, 40100, Kenya
-
GSK Investigational Site
Cape Town, 7500, South Africa
-
GSK Investigational Site
Durban, 4001, South Africa
-
GSK Investigational Site
Johannesburg, 1862, South Africa
-
GSK Investigational Site
Bangkok, 10330, Thailand
-
GSK Investigational Site
Bangkok, 10700, Thailand
-
GSK Investigational Site
Chiang Mai, 50200, Thailand
Conditions
Explore the condition pages connected to this study.